A perspective on potential antibody-dependent enhancement of SARS-CoV-2
VIR Biotechnology (United States) · Stanford University · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
535
total citations
- FWCI
- 12.38
- Percentile
- 100%
- References
- 145
Citations per year
Authors
9- AMAnn M. ArvinCorresponding
VIR Biotechnology (United States), Stanford University
- KFKatja Fink
Vir Biotechnology (Switzerland), VIR Biotechnology (United States)
- MSMichael Schmid
Vir Biotechnology (Switzerland), VIR Biotechnology (United States)
- ALAndrea L. Cathcart
VIR Biotechnology (United States)
- RSRoberto Spreafico
VIR Biotechnology (United States)
Topics & keywords
Topics
Keywords
- Disease
- Antibody
- Antibody-dependent enhancement
- Immune system
- Immunology
- Medicine
- Immunity
- Pandemic
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.